About
Cassava Sciences is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases, primarily Alzheimer's disease, with its leading drug candidate simufilam.
Explore Cassava Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.